FDA Inspection 1050946 — Fresenius Kabi Deutschland GmbH
The FDA completed an inspection of Fresenius Kabi Deutschland GmbH on Apr 11, 2018 in Friedberg (Hessen). The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 11, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Friedberg (Hessen) (Germany)